PHYL | USHY | PHYL / USHY | |
Gain YTD | 6.578 | 5.742 | 115% |
Net Assets | 409M | 25B | 2% |
Total Expense Ratio | 0.39 | 0.08 | 488% |
Turnover | 47.00 | 21.00 | 224% |
Yield | 7.79 | 6.72 | 116% |
Fund Existence | 7 years | 8 years | - |
PHYL | USHY | |
---|---|---|
RSI ODDS (%) | 2 days ago36% | 2 days ago47% |
Stochastic ODDS (%) | 2 days ago45% | 2 days ago52% |
Momentum ODDS (%) | 2 days ago62% | 2 days ago64% |
MACD ODDS (%) | 2 days ago49% | 2 days ago53% |
TrendWeek ODDS (%) | 2 days ago57% | 2 days ago59% |
TrendMonth ODDS (%) | 2 days ago55% | 2 days ago56% |
Advances ODDS (%) | 7 days ago60% | 7 days ago61% |
Declines ODDS (%) | 5 days ago50% | 12 days ago54% |
BollingerBands ODDS (%) | 2 days ago24% | 2 days ago38% |
Aroon ODDS (%) | 2 days ago48% | 2 days ago54% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CMDYX | 13.96 | 0.04 | +0.29% |
Columbia Mid Cap Index Inst3 | |||
MCLOX | 16.76 | -0.01 | -0.06% |
BlackRock Global Allocation Inv C | |||
EAALX | 22.46 | -0.07 | -0.31% |
Eaton Vance Atlanta Capital Focused Gr A | |||
AHSZX | 19.57 | -0.07 | -0.36% |
Alger Health Sciences Z | |||
OSPPX | 6.45 | -0.04 | -0.62% |
Invesco SteelPath MLP Alpha Plus R6 |
A.I.dvisor tells us that PHYL and EXE have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHYL and EXE's prices will move in lockstep.
Ticker / NAME | Correlation To PHYL | 1D Price Change % | ||
---|---|---|---|---|
PHYL | 100% | N/A | ||
EXE - PHYL | 29% Poorly correlated | -2.21% |